Latest / Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology
Early Tirofiban After Thrombolysis for Ischemic Stroke (ASSET-IT trial)
This original article published in the New England Journal of Medicine reports the findings of the ASSET-IT trial, a phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial. This study investigates the efficacy and safety of early tirofiban infusion after standard intravenous thrombolysis for patients experiencing acute ischemic noncardioembolic stroke. The trial's primary outcome demonstrates that early administration of tirofiban significantly increases the likelihood of an excellent functional outcome at 90 days compared to placebo. However, the study also notes a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.